Cardiovascular Complication
52
14
17
21
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.9%
1 terminated out of 52 trials
95.5%
+8.9% vs benchmark
12%
6 trials in Phase 3/4
0%
0 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (52)
InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection
Re-infusion of Unwashed Shed Blood During Off-pump Surgery
WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
Alpha Lipoic Acid in Pediatrics on Hemodialysis
The Effect Of Perioperative Results On Mortality In Coronary Artery Bypass Surgery
Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial
Early Diagnosis and Cardiovascular Risk Stratification in Children Exposed to Cancer Therapies
EuroSCORE-II and POSPOM in Cardiac Surgery
An 18-year Follow-up Study on OSA in a Population-based Cohort
Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients
Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors
Clinical Determinants and Adverse Reactions to Tropicamide/Phenylephrine in Hospitalized Patients.
Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery
Blood Pressure Management on Cardiovascular AdveRse Events After Major Abdominal Surgery
Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)
Scrub Typhus Infection Induced Cardiovascular Disease
At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure